Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection

Background: Previous studies suggest S100A9 is a promising biomarker for prognosis in cancer, including hepatocellular carcinoma (HCC). We examined the utility of serum S100A9 in predicting prognosis in HCC after curative resection. Methods: We conducted a retrospective study of 379 HCC patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jun, Gu, Feng, Fang, Hua, Qu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360318/
https://www.ncbi.nlm.nih.gov/pubmed/30719134
http://dx.doi.org/10.7150/jca.28409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360318/
https://www.ncbi.nlm.nih.gov/pubmed/30719134
http://dx.doi.org/10.7150/jca.28409

Ejemplares similares